GlobeNewswire

New MindManager 11 for Mac: Visually Capture, Organize, and Share Information to Drive Project and Business Success

Dela

Powerful mind mapping and information visualization software introduces its most robust Mac version yet; complete with new diagram types, an expanded template library, advanced mapping capabilities, and improved sharing options

 

OTTAWA, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Introduced today, MindManager® 11 for Mac brings new elegance and efficiency to the way individuals and teams organize ideas, tackle tasks, and achieve their goals. Already a leader in mind mapping and information visualization on the Mac, MindManager's new release offers advanced mapping capabilities, new diagram types and templates, and easy ways to share and publish your work - all delivered within a redesigned interface optimized to enhance productivity.

Individuals, small businesses, and global organizations rely upon MindManager to efficiently brainstorm and organize ideas, communicate knowledge effectively, and execute project success. MindManager enables users to turn unstructured ideas and information into dynamic mind maps, timelines, flowcharts, and more, so they can streamline efforts, supercharge productivity, and pre-emptively reveal risks and opportunities.

"MindManager 11 for Mac offers powerful ways to visualize data, making it possible to unlock the potential of your organization's information, strategies, and plans," said Michael Deutch, Vice President of Products for MindManager. "When 77 percent of respondents to a recent MindManager workplace survey told us their organizations were seeing poor productivity and failed projects because not enough time is spent on ensuring alignment, it was clear that businesses need to adopt better ways to define common goals and get their teams behind them."

"MindManager is an essential tool to do just that. And with this new release, we're delivering a robust application that leverages our team's 20 years of information-visualization expertise to bring Mac users the capabilities they need to take control of their work and world," added Deutch.  

MindManager 11 for Mac is packed with more power and possibility with updates including:

  • NEW!  Visualize paths to growth and profit with the expanded template library
    More than a dozen new and improved templates and diagram formats will help users see ideas, plans, and possibilities in ways that empower bigger thinking, smarter decisions, and better outcomes. Timelines, workflow diagrams, and concept maps illuminate correct paths and drive efficient action; Venn, onion, and swim lane diagrams give a clearer understanding of relationships and intersections; and customizable matrices empower users to correlate ideas and quickly assess risk, reward, value, and priority.
  • NEW! Reinvent the way you use MindManager with Digital Architect
    With the expanded library of background objects and map-making capabilities, existing templates can be customized with shapes, images, text boxes, swim lanes, dividers, and more to clarify relationships and accountability, or whole new structures can be built to organize and understand the big picture. Now users have free rein over the way their map looks, the story it tells, and the results it helps achieve.
  • NEW! Work more efficiently and effectively with advanced mapping capabilities
    With advanced mapping features and task management tools, maps and diagrams are easier to work with, tell a more robust story, and drive better outcomes - faster than ever. Now multiple maps can be opened in a single application for easy multitasking; data can be rolled up from multiple maps into a single dashboard for at-a-glance understanding; multiple external links can be added to a single topic to create a one-stop resource repository; link titles can be customized for instant context, and more. 
  • NEW! Publish and share maps easily with anyone, anywhere
    Users can now introduce a new level of polish, professionalism, and impact into the map viewing experience with the Interactive HTML5 Presentation Export. Clear, simple controls make navigation effortless, even for novice recipients, and keep their focus on the map's substance, not its structure. And the new Publish tool makes it quick and easy for users to share brainstorms with colleagues, show proposals and plans to customers, or publish MindManager content to the web for others to learn from and build on.
  • NEW! Built natively for Mac, compatible with your entire organization
    Designed to take advantage of the power of High Sierra, version 11 is MindManager's biggest Mac update yet, loaded with new features. This release assures that anyone in a business - whether they're running Mac or Windows - can use the power of the latest diagramming styles and advanced mapping capabilities to achieve alignment and project success. Plus, with Readers for Mac and Windows available to MindManager Enterprise customers, maps can be shared with everyone on the team, even if they don't have the full MindManager software installed.

Pricing and Availability
MindManager 11 for Mac is available now in English, French, and German as an individual license for $179.00 (USD) / £178.80 / €213.01 suggested retail price (SRP). Upgrade pricing for the individual license is $89.00 (USD) / £90.00 / €105.91 SRP. UK and European prices are inclusive of VAT.

MindManager 11 for Mac is also available as part of MindManager Enterprise, available for teams with five licenses and more.

MindManager Workplace Survey
For more information on the MindManager Workplace Survey or to download the survey report, please visit www.mindjet.com/workplace-productivity-and-planning-report/
   
About MindManager
Mindjet's MindManager helps individuals, teams, and enterprises do great work faster by simplifying the way they capture, organize, and share information. Transforming scattered ideas and unstructured data into dynamic visual maps, MindManager gives people a clearer understanding and greater control over their time, work, and world. Millions of global users choose MindManager to brainstorm ideas, plan and execute projects, and communicate knowledge. Mindjet is a division of Corel Corporation. For more information, please visit www.mindjet.com.

© 2018 Corel Corporation. All rights reserved. Corel, MindManager, the MindManager logo, and Mindjet are trademarks or registered trademarks of Corel Corporation and/or its subsidiaries in Canada, the U.S., and elsewhere. All other trademarks mentioned herein are the property of their respective owners. Patents: www.corel.com/patent

Media Contact
Lucy Screnci
lucy.screnci@corel.com
www.mindjet.com

Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/3b6f8f89-8c82-4b5f-bbec-66862fb90f08 http://www.globenewswire.com/NewsRoom/AttachmentNg/c9465077-ef03-4ea8-9a69-8adb53064522 http://www.globenewswire.com/NewsRoom/AttachmentNg/6478c4f0-b97a-468c-b155-58566ede22d7 http://www.globenewswire.com/NewsRoom/AttachmentNg/f2e8f08d-631a-4316-ba26-5656b1b360c8

A video accompanying this release is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/05ef6ed2-8e0a-4391-9730-187c8bcd55bf




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Corel via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum